Agilent Technologies, Inc. $A Shares Purchased by Findlay Park Partners LLP

Key Points

• Findlay Park Partners LLP increased its stake in Agilent Technologies by 17.6%, owning 1,334,010 shares valued at approximately $156 million as of the latest SEC filing.
• Agilent Technologies reported $1.31 EPS for its most recent quarter, surpassing analysts' expectations of $1.26, and noted a 6% increase in revenue year-over-year.
• The consensus rating for Agilent Technologies is a "Moderate Buy," with an average price target of $138.83 set by various research firms.

Findlay Park Partners LLP grew its stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 17.6% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,334,010 shares of the medical research company's stock after acquiring an additional 199,900 shares during the quarter. Findlay Park Partners LLP owned about 0.47% of Agilent Technologies worth $156,052,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Sunbelt Securities Inc. boosted its position in Agilent Technologies by 640.0% in the fourth quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company's stock valued at $30,000 after buying an additional 192 shares during the last quarter. Whipplewood Advisors LLC boosted its holdings in shares of Agilent Technologies by 286.2% in the 1st quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company's stock valued at $29,000 after acquiring an additional 186 shares during the last quarter. Wood Tarver Financial Group LLC purchased a new stake in shares of Agilent Technologies in the 4th quarter valued at $34,000. Stone House Investment Management LLC purchased a new stake in shares of Agilent Technologies in the 1st quarter valued at $30,000. Finally, Opal Wealth Advisors LLC purchased a new stake in shares of Agilent Technologies in the 1st quarter valued at $31,000.

Agilent Technologies Price Performance

Shares of Agilent Technologies stock traded up $6.48 on Thursday, reaching $125.17. The company's stock had a trading volume of 3,886,267 shares, compared to its average volume of 1,310,906. The company has a market capitalization of $35.56 billion, a P/E ratio of 29.38, a PEG ratio of 3.60 and a beta of 1.22. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $153.84. The stock has a 50-day moving average price of $118.18 and a 200-day moving average price of $116.76. The company has a quick ratio of 1.60, a current ratio of 2.09 and a debt-to-equity ratio of 0.55.

Agilent Technologies (NYSE:A - Get Free Report) last posted its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, meeting analysts' consensus estimates of $1.37. The business had revenue of $1.74 billion during the quarter, compared to analysts' expectations of $1.67 billion. Agilent Technologies had a return on equity of 25.88% and a net margin of 17.97%.The business's revenue was up 10.1% compared to the same quarter last year. During the same period in the previous year, the business earned $1.32 earnings per share. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Analyst Ratings Changes

Several analysts have recently commented on A shares. TD Cowen upped their price objective on shares of Agilent Technologies to $150.00 and gave the company a "buy" rating in a report on Thursday, May 29th. UBS Group dropped their price objective on shares of Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating on the stock in a report on Thursday, May 29th. Wells Fargo & Company upped their price objective on shares of Agilent Technologies from $135.00 to $140.00 and gave the company an "overweight" rating in a report on Thursday. Evercore ISI decreased their price target on Agilent Technologies from $130.00 to $128.00 and set an "in-line" rating for the company in a report on Thursday. Finally, Barclays boosted their price target on Agilent Technologies from $115.00 to $125.00 and gave the company an "equal weight" rating in a report on Tuesday, June 24th. Six research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $139.25.

Insider Activity

In other news, CEO Padraig Mcdonnell sold 1,508 shares of Agilent Technologies stock in a transaction that occurred on Tuesday, July 1st. The stock was sold at an average price of $117.44, for a total value of $177,099.52. Following the sale, the chief executive officer directly owned 37,448 shares of the company's stock, valued at $4,397,893.12. The trade was a 3.87% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.